Brazzelli M, McKenzie L, Fielding S, Fraser C, Clarkson J, Kilonzo M, Waugh N
Health Services Research Unit, Institute of Applied Health Sciences, University of Aberdeen, UK.
Health Technol Assess. 2006 May;10(16):iii-iv, ix-80. doi: 10.3310/hta10160.
To assess the effectiveness and cost-effectiveness of HealOzone (CurOzone USA Inc., Ontario, Canada) for the management of pit and fissure caries, and root caries. The complete HealOzone procedure involves the direct application of ozone gas to the caries lesion on the tooth surface, the use of a remineralising solution immediately after application of ozone and the supply of a 'patient kit', which consists of toothpaste, oral rinse and oral spray all containing fluoride.
Electronic databases up to May 2004 (except Conference Papers Index, which were searched up to May 2002).
A systematic review of the effectiveness of HealOzone for the management of tooth decay was carried out. A systematic review of existing economic evaluations of ozone for dental caries was also planned but no suitable studies were identified. The economic evaluation included in the industry submission was critically appraised and summarised. A Markov model was constructed to explore possible cost-effectiveness aspects of HealOzone in addition to current management of dental caries.
Five full-text reports and five studies published as abstracts met the inclusion criteria. The five full-text reports consisted of two randomised controlled trials (RCTs) assessing the use of HealOzone for the management of primary root caries and two doctoral theses of three unpublished randomised trials assessing the use of HealOzone for the management of occlusal caries. Of the abstracts, four assessed the effects of HealOzone for the management of occlusal caries and one the effects of HealOzone for the management of root caries. Overall, the quality of the studies was modest, with many important methodological aspects not reported (e.g. concealment of allocation, blinding procedures, compliance of patients with home treatment). In particular, there were some concerns about the choice of statistical analyses. In most of the full-text studies analyses were undertaken at lesion level, ignoring the clustering of lesions within patients. The nature of the methodological concerns was sufficient to raise doubts about the validity of the included studies' findings. A quantitative synthesis of results was deemed inappropriate. On the whole, there is not enough evidence from published RCTs on which to judge the effectiveness of ozone for the management of both occlusal and root caries. The perspective adopted for the study was that of the NHS and Personal Social Services. The analysis, carried out over a 5-year period, indicated that treatment using current management plus HealOzone cost more than current management alone for non-cavitated pit and fissure caries (40.49 pounds versus 24.78 pounds), but cost less for non-cavitated root caries ( 14.63 pounds versus 21.45 pounds). Given the limitations of the calculations these figures should be regarded as illustrative, not definitive. It was not possible to measure health benefits in terms of quality-adjusted life-years, due to uncertainties around the evidence of clinical effectiveness, and to the fact that the adverse events avoided are transient (e.g. pain from injection of local anaesthetic, fear of the drill). One-way sensitivity analysis was applied to the model. However, owing to the limitations of the economic analysis, this should be regarded as merely speculative. For non-cavitated pit and fissure caries, the HealOzone option was always more expensive than current management when the probability of cure using the HealOzone option was 70% or lower. For non-cavitated root caries the costs of the HealOzone comparator were lower than those of current management only when cure rates from HealOzone were at least 80%. The costs of current management were higher than those of the HealOzone option when the cure rate for current management was 40% or lower. One-way sensitivity analysis was also performed using similar NHS Statement of Dental Remuneration codes to those that are used in the industry submission. This did not alter the results for non-cavitated pit fissure caries as the discounted net present value of current management remained lower than that of the HealOzone comparator ( 22.65 pounds versus 33.39 pounds).
Any treatment that preserves teeth and avoids fillings is welcome. However, the current evidence base for HealOzone is insufficient to conclude that it is a cost-effective addition to the management and treatment of occlusal and root caries. To make a decision on whether HealOzone is a cost-effective alternative to current preventive methods for the management of dental caries, further research into its clinical effectiveness is required. Independent RCTs of the effectiveness and cost-effectiveness of HealOzone for the management of occlusal caries and root caries need to be properly conducted with adequate design, outcome measures and methods for statistical analyses.
评估HealOzone(美国CurOzone公司,加拿大安大略省)用于治疗窝沟龋和根面龋的有效性及成本效益。完整的HealOzone治疗程序包括将臭氧气体直接应用于牙齿表面的龋损处,在应用臭氧后立即使用再矿化溶液,以及提供一个“患者套装”,其中包括含氟牙膏、漱口水和口腔喷雾剂。
截至2004年5月的电子数据库(会议论文索引检索至2002年5月)。
对HealOzone治疗龋齿的有效性进行了系统综述。还计划对现有的臭氧治疗龋齿的经济学评价进行系统综述,但未找到合适的研究。对行业提交材料中包含的经济学评价进行了严格评估和总结。构建了一个马尔可夫模型,以探讨HealOzone在当前龋齿管理之外可能的成本效益方面。
五篇全文报告和五篇以摘要形式发表的研究符合纳入标准。五篇全文报告包括两项评估HealOzone用于治疗原发性根面龋的随机对照试验(RCT),以及两篇博士论文,其中包含三项未发表的评估HealOzone用于治疗咬合面龋的随机试验。在摘要中,四项评估了HealOzone治疗咬合面龋的效果,一项评估了HealOzone治疗根面龋的效果。总体而言,研究质量一般,许多重要的方法学方面未报告(如分配隐藏、盲法程序、患者家庭治疗的依从性)。特别是,对统计分析的选择存在一些担忧。在大多数全文研究中,分析是在病损水平进行的,忽略了患者体内病损的聚集情况。方法学问题的性质足以让人对纳入研究结果的有效性产生怀疑。认为对结果进行定量综合不合适。总体而言,已发表的RCT中没有足够的证据来判断臭氧治疗咬合面龋和根面龋的有效性。该研究采用的视角是英国国家医疗服务体系(NHS)和个人社会服务。在5年期间进行的分析表明,对于非龋洞型窝沟龋,采用当前管理方法加HealOzone治疗的成本高于仅采用当前管理方法(40.49英镑对24.78英镑),但对于非龋洞型根面龋,成本则较低(14.63英镑对21.45英镑)。鉴于计算的局限性,这些数字应被视为说明性的,而非确定性的。由于临床有效性证据存在不确定性,以及避免的不良事件是短暂的(如局部麻醉注射引起的疼痛、对牙钻的恐惧)这一事实,无法用质量调整生命年衡量健康效益。对模型进行了单向敏感性分析。然而,由于经济分析的局限性,这应仅被视为推测性的。对于非龋洞型窝沟龋,当使用HealOzone治疗的治愈率为70%或更低时,HealOzone方案总是比当前管理方法更昂贵。对于非龋洞型根面龋,只有当HealOzone的治愈率至少为80%时,HealOzone比较方案的成本才低于当前管理方法。当当前管理方法的治愈率为40%或更低时,当前管理方法的成本高于HealOzone方案。还使用与行业提交材料中类似的NHS牙科薪酬声明代码进行了单向敏感性分析。这并没有改变非龋洞型窝沟龋的结果,因为当前管理方法的贴现净现值仍然低于HealOzone比较方案(22.65英镑对33.39英镑)。
任何能够保留牙齿并避免补牙的治疗方法都是受欢迎的。然而,目前关于HealOzone的证据基础不足以得出它是治疗咬合面龋和根面龋的一种具有成本效益的补充方法的结论。要确定HealOzone是否是当前预防方法治疗龋齿的一种具有成本效益的替代方法,需要对其临床有效性进行进一步研究。需要以适当的设计、结局指标和统计分析方法,正确开展关于HealOzone治疗咬合面龋和根面龋的有效性及成本效益的独立随机对照试验。